The New Germany Fund, Inc. (GF) vs Medibank Private Limited (MPL.AX)
The same free fields, in the same order, for both companies, so a figure on one line can be read straight across.
This page states measurements and nothing else. It does not rank the two companies, name one of them, or draw a conclusion from the figures.
Data as of Oct 27, 2026, for both companies.
The figures, field by field
A dash means the snapshot carries no figure for that company on that line. A line is dropped only when neither company has it, so a dash beside a figure is a fact about coverage, not about either company.
| GF | MPL.AX | |
|---|---|---|
| Sector | Financial Services | Financial Services |
| Industry | Asset Management | Insurance - Specialty |
| Size band | SMALL | MID |
| Listing | NYSE | ASX |
| Country | Germany | Australia |
| Theme | asset-management | health-insurance |
| Price and returns | ||
| Last close | $10.19 | 5.05 AUD |
| Return · 1 week | −1.26% | +5.65% |
| Return · 1 month | −4.94% | +10.99% |
| Return · 3 months | −9.90% | −3.63% |
| Return · year to date | −10.06% | +6.99% |
| Return · 1 year | −7.09% | +7.44% |
| Distance from the 52-week highThe last close measured against the highest close of the past 52 weeks. | −18.41% | −4.90% |
| 52-week high | $12.49 | 5.31 AUD |
| 52-week low | $9.98 | 4.06 AUD |
| Size and turnover | ||
| Market value · USDConverted to US dollars, so two companies listed in different currencies sit under one heading. | $166.01M | $9.76B |
| Turnover · median day, USDThe median value traded in a session over the past 50 sessions. | $207.37K | $30.90M |
| Employees | — | 5,001 |
| Valuation | ||
| Price to earnings · trailing | n/a (negative earnings) | 19.87× |
| Price to earnings · forward | — | 17.02× |
| Price to sales | 47.70× | 1.35× |
| Price to book | 0.82× | 5.18× |
| Enterprise value to EBITDA | — | 9.52× |
| Enterprise value to revenue | 52.64× | 1.00× |
| Earnings per share · trailing | -0.47 | 0.23 |
| Profitability | ||
| Operating margin | 55.17% | 10.72% |
| Profit margin | −214.44% | 6.87% |
| Return on equity | −3.58% | 27.23% |
| Return on assets | 0.21% | 12.65% |
| Growth | ||
| Revenue growth | −5.40% | +12.60% |
| Earnings growth | −97.10% | +109.90% |
| Balance sheet and payout | ||
| Debt / equity (%) | 8.96 | 11.36 |
| Current ratio | 1.05 | 1.96 |
| Dividend yield | 2.75% | 4.22% |
| Payout ratio | 4.32% | 79.74% |
| Trend and volatility | ||
| RSI · 14 | 34.69 | 75.65 |
| ADX · 14 | 33.42 | 30.50 |
| 50-day average | $10.91 | 4.69 AUD |
| 200-day average | $11.41 | 4.71 AUD |
| Average true range · share of priceAverage true range over 14 sessions, stated as a share of the last close, so it can be read across two share prices. | 1.49% | 1.82% |
The full GF analysis
Everything this table leaves out for The New Germany Fund, Inc.: the plain-language summary and key points, the accumulation read, signal history, full fundamentals, market context, and the case each side of the GF argument makes.
$9.90 per stock, one time, 30 days of access.
Open the full GF analysisThe full MPL.AX analysis
Everything this table leaves out for Medibank Private Limited: the plain-language summary and key points, the accumulation read, signal history, full fundamentals, market context, and the case each side of the MPL.AX argument makes.
$9.90 per stock, one time, 30 days of access.
Open the full MPL.AX analysis